Actavis Laboratories UT, Inc | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Actavis Laboratories UT, Inc

Sort by

Viewing results 1‒25 of 34

Pharmaceuticals sector
Mylan drops as AGs look to expand generic drug-pricing lawsuit
...Actavis Holdco U.S., Inc.; Actavis Pharma, Inc.; Ascend Laboratories, LLC; Apotex Corp.; Dr....
October 31, 2017
US & Canadian companies
Carl Icahn buys ‘big’ stake in Allergan
...Actavis acquired Allergan, which makes the Botox cosmetic, last year and adopted its name after the deal closed....
May 31, 2016
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Law
Poison pill proves to be a deal-breaker
...The tie-up with Actavis also paved the way for further dealmaking....
December 8, 2015
US & Canadian companies
Pfizer’s Ian Read looks to count Allergan merger as his legacy
...But Allergan’s combination last year with Actavis — itself newly enlarged through a dizzying series of deals — created a company that fitted his two main criteria....
November 27, 2015
US & Canadian companies
Allergan signals appetite for new mega deal after $41bn disposal
...So could Mr Saunders be about to put on his laboratory coat and buy a company such as Biogen or AbbVie? “It’s possible....
July 27, 2015
US & Canadian companies
Shire Pharmaceuticals eyes the big league with Baxalta bid
...Others include Actavis, which bought Allergan, the maker of Botox, last year for $66bn and has since adopted the Allergan name....
August 4, 2015
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
News in-depthUS & Canadian companies
Allergan chief remains coy over Pfizer talks
...Most recently it bought Botox maker Allergan for $70bn and ditched the company’s previous name, Actavis....
November 5, 2015
US & Canadian companies
Hungry Actavis pauses to digest Allergan
...He says that of the world’s top 20 best-selling drugs, just “two or three were truly discovered in the laboratory”, with the rest being new takes on existing compounds....
January 21, 2015
US & Canadian companies
No end in sight to wave of pharma dealmaking
...resisted Teva’s advances, preferring instead to pursue its own $33bn hostile bid for Perrigo, a Dublin-based generic drugmaker, just two months after completing a $5.3bn acquisition of products from Abbott Laboratories...
April 26, 2015
US & Canadian companies
AbbVie joins the pharma chain reaction
...The frenzy began when Actavis bought Forest Laboratories for $25bn early last year and has continued ever since, involving almost every big drugmaker and many supporting actors from the biotech and medical...
March 6, 2015
US & Canadian companies
Allergan-Actavis deal follows battle for soul of pharma
...For Mr Pearson, modern drugmaking is stuck in the past, clinging to a postwar business model where armies of white-coated scientists toil away in laboratories....
November 17, 2014
Pharmaceuticals sector
Allergan: three’s company
...It bought Watson Pharmaceuticals for $6bn (2012), Ireland-domiciled Warner Chilcott for $9bn (2013) and Forest Laboratories for $25bn (2014)....
October 8, 2014
News in-depthThe Big Read
Healthcare: The race to cure rising drug costs
...Actavis had stopped selling the pill and told doctors to move patients to a newer version, Namenda XR....
February 10, 2015
US & Canadian companies
Valeant chief Pearson admits ‘miscalculation’ in Allergan pursuit
...The company had five drug applications approved by the US regulator last year, most of which originated in its own laboratories, he says....
January 21, 2015
News in-depthThe Big Read
Biotech: Making sense of the science
...There probably are,” says Brent Saunders, the chief executive of Actavis who engineered the biggest takeover of 2014 — the $70.5bn acquisition of Botox maker Allergan....
April 13, 2015
FT Live
Global Private Banking Awards 2024
Celebrating excellence in wealth management
Thursday, 7 NovemberThe Landmark London, London, UK
US & Canadian companies
Actavis buys Forest Laboratories for $25bn
...Actavis, the highly acquisitive Dublin-based drugs maker, has agreed to buy New York’s Forest Laboratories for $25bn, its biggest purchase to date....
February 18, 2014
LexUS & Canadian companies
Actavis / Forest: roll up, tax down
...So it makes sense that Actavis shares rose 8 per cent on news that it would pay $7bn in cash and issue $18.5bn worth of its shares (a 51 per cent increase in the share count) to buy Forest Laboratories....
February 18, 2014
US & Canadian companies
Actavis chief Bisaro finds prescription for growth
...The $25bn purchase of Forest Laboratories, announced on Tuesday, is by far the largest transaction he has overseen so far....
February 18, 2014
Person in the NewsStephen Foley
Carl Icahn, obsessive activist investor
...Partly because his four-year campaign of pressure on the drugmaker Forest Laboratories came to lucrative fruition in a $25bn sale to Actavis....
February 21, 2014
US equities
Eli Lilly jumps after cancer drug trial
...Analysts at Goldman said the acquisitive Dublin-based company would see a “substantial” sales and profit improvement if it is able to complete its $25bn buyout of New York’s Forest Laboratories....
February 19, 2014
FT AlphavilleCardiff Garcia
The Closer
...FT EVENING ROUND-UP Actavis buys Forest Laboratories for $25bn: “Actavis, the highly acquisitive Dublin-based drugs maker, has agreed to buy New York’s Forest Laboratories for $25bn, its biggest purchase...
February 18, 2014
US & Canadian companies
Tax thread runs through pharma deals
...Actavis, for example, in February agreed to pay $25bn for Forest Laboratories of the US, giving the Dublin-based generics maker access to a range of specialist drugs....
April 7, 2014
US & Canadian companies
Cinven buys research group Medpace
...Most of the activity has been in the US, including last week’s $25bn acquisition of New York-based Forest Laboratories by Actavis, one of the world’s biggest generic drugmakers....
February 24, 2014
US & Canadian companies
Mylan weighs move for Swedish rival Meda
...Other big deals in the sector have included the $25bn takeover of Forest Laboratories by Actavis in February, another deal that involved a generic drugmaker moving into higher-value branded products....
April 4, 2014
US & Canadian companies
Pfizer sets stage for corporate showdown
...Companies including Horizon Pharma, Perrigo, Actavis, Alkermes, Jazz Pharmaceuticals, Covidien, Forest Laboratories and Endo Health Solutions have moved to Ireland, in deals expected to cut companies’ overall...
April 28, 2014

Previous pagePage 1 of 2Next page